Rheumatoid Arthritis. Rheumatoid arthritis, unspecified
Conditions
Interventions
Intervention 1: Intervention Groups: bromocriptine 2.5 mg BD in 6 months. Intervention 2: Control Group : to receive placebo for 6 months.
Treatment - Drugs
Placebo
Intervention Groups: bromocriptine 2.5 mg BD in 6 months
Control Group : to receive placebo for 6 months
Sponsors
Kashan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with rheumatoid arthritis by American College of Rheumatology criteria (ACR) Exclusion criteria: Patients who do not regularly take their medications
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of joint pain. Timepoint: Before the intervention, and at 1, 2, 4 and 6 months. Method of measurement: Visual analog scale (VAS.;Number of swollen joints. Timepoint: before the start intervention and end of 1, 2, 4 and 6 months after intervention. Method of measurement: Examination.;The number of painful joints. Timepoint: Before the intervention, and at months 1, 2, 4 and 6 after. Method of measurement: The patient's history. | — |
Secondary
| Measure | Time frame |
|---|---|
| ESR. Timepoint: Before the intervention and after 1, 2, 4 and 6 months. Method of measurement: lab test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Kamal Esalatmanesh
kashan Univercity of Medical Sciences
Outcome results
None listed